Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05609578
Title Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | HUN | GRC | FRA | ESP | CHE | BRA


No variant requirements are available.